| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 1B | +10% |
| Gross Profit | 943.6MM | - |
| Cost Of Revenue | 69.8MM | +16% |
| Operating Income | 187.3MM | -13% |
| Operating Expenses | 756.3MM | - |
| Net Income | 201.1MM | +17% |
| R&D | 444.5MM | +18% |
| G&A | 293.9MM | +10% |
| Interest Expense | 804K | +29% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
Private investments in public equities, or PIPEs, are all the rage in biotech, but some investors resent the sharing of nonpublic information.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
WILMINGTON, Del., April 11, 2024--Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024.
A biotech executive committed insider trading when he bet on a competitor’s stock, believing the shares would rise when news about his own company hit the market, a jury found Friday. The civil-fraud verdict against Matthew Panuwat, former head of business development for pharmaceutical company Medivation, marks a significant expansion of insider-trading law. The law has mostly been used to punish people who misuse nonpublic information by buying or selling their company’s stock before a big...
WILMINGTON, Del. and HONG KONG, April 01, 2024--Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts. If you want to skip our coverage of the latest happenings surrounding one of America’s most widely followed stock indexes, then you can take a look at the 5 Best S&P 500 Stocks To Buy […]
WILMINGTON, Del., March 29, 2024--Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mesoblast (MESO) gains as the FDA states that the available phase III data for lead candidate, remestemcel-L, is sufficient to support a regulatory filing for pediatric SR-aGVHD indication.
(Bloomberg) -- A lawyer for the US Securities and Exchange Commission told a jury that a former biotech executive’s $120,000 windfall on a trade in a competing company’s stock was “like betting on a game when you know who’s going to win” because he knew the pending takeover of his firm would likely boost its rival.Most Read from BloombergTrump’s Net Worth Hits $6.5 Billion, Making Him One of World’s 500 Richest PeopleTrump Vows to Pay Fraud Trial Bond Cut by 68% to $175 MillionBiden Gains Ground